H P Parkman1, E K Hallinan2, W L Hasler3, G Farrugia4, K L Koch5, L Nguyen6, W J Snape7, T L Abell8, R W McCallum9, I Sarosiek9, P J Pasricha2, J Clarke2, L Miriel2, J Tonascia2, F Hamilton10. 1. Temple University, Philadelphia, PA, USA. 2. Johns Hopkins University, Baltimore, MD, USA. 3. University of Michigan, Ann Arbor, MI, USA. 4. Mayo Clinic, Rochester, MN, USA. 5. Wake Forest University, Winston-Salem, NC, USA. 6. Stanford University, Palo Alto, CA, USA. 7. California Pacific Medical Center, San Francisco, CA, USA. 8. University of Louisville, Louisville, KY, USA. 9. Texas Tech University, El paso, TX, USA. 10. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA.
Abstract
BACKGROUND: Early satiety (ES) and postprandial fullness (PPF) are often present in gastroparesis, but the importance of these symptoms in gastroparesis has not been well-described. The aims were: (i) Characterize ES and PPF in patients with gastroparesis. (ii) Assess relationships of ES and PPF with etiology of gastroparesis, quality of life, body weight, gastric emptying, and water load testing. METHODS: Gastroparetic patients filled out questionnaires assessing symptoms (PAGI-SYM) and quality of life (PAGI-QOL, SF-36v2). Patients underwent gastric emptying scintigraphy and water load testing. KEY RESULTS: 198 patients with gastroparesis (134 IG, 64 DG) were evaluated. Early satiety was severe or very severe in 50% of patients. Postprandial fullness was severe or very severe in 60% of patients. Severity scores for ES and PPF were similar between idiopathic and diabetic gastroparesis. Increasing severity of ES and PPF were associated with other gastroparesis symptoms including nausea/vomiting, satiety/early fullness, bloating, and upper abdominal pain and GERD subscores. Increasing severity of ES and PPF were associated with increasing gastroparesis severity, decreased BMI, decreased quality of life from PAGI-QOL and SF-36 physical health. Increasing severity of ES and PPF were associated with increasing gastric retention of a solid meal and decreased volume during water load test. CONCLUSIONS & INFERENCES: Early satiety and PPF are commonly severe symptoms in both diabetic and idiopathic gastroparesis. Early satiety and PPF severity are associated with other gastroparesis symptom severities, body weight, quality of life, gastric emptying, and water load testing. Thus, ES and PPF are important symptoms characterizing gastroparesis. ClinicalTrials.gov number: NCT NCT01696747.
BACKGROUND: Early satiety (ES) and postprandial fullness (PPF) are often present in gastroparesis, but the importance of these symptoms in gastroparesis has not been well-described. The aims were: (i) Characterize ES and PPF in patients with gastroparesis. (ii) Assess relationships of ES and PPF with etiology of gastroparesis, quality of life, body weight, gastric emptying, and water load testing. METHODS: Gastroparetic patients filled out questionnaires assessing symptoms (PAGI-SYM) and quality of life (PAGI-QOL, SF-36v2). Patients underwent gastric emptying scintigraphy and water load testing. KEY RESULTS: 198 patients with gastroparesis (134 IG, 64 DG) were evaluated. Early satiety was severe or very severe in 50% of patients. Postprandial fullness was severe or very severe in 60% of patients. Severity scores for ES and PPF were similar between idiopathic and diabeticgastroparesis. Increasing severity of ES and PPF were associated with other gastroparesis symptoms including nausea/vomiting, satiety/early fullness, bloating, and upper abdominal pain and GERD subscores. Increasing severity of ES and PPF were associated with increasing gastroparesis severity, decreased BMI, decreased quality of life from PAGI-QOL and SF-36 physical health. Increasing severity of ES and PPF were associated with increasing gastric retention of a solid meal and decreased volume during water load test. CONCLUSIONS & INFERENCES: Early satiety and PPF are commonly severe symptoms in both diabetic and idiopathic gastroparesis. Early satiety and PPF severity are associated with other gastroparesis symptom severities, body weight, quality of life, gastric emptying, and water load testing. Thus, ES and PPF are important symptoms characterizing gastroparesis. ClinicalTrials.gov number: NCT NCT01696747.
Authors: T L Abell; R K Bernstein; T Cutts; G Farrugia; J Forster; W L Hasler; R W McCallum; K W Olden; H P Parkman; C R Parrish; P J Pasricha; C M Prather; E E Soffer; R Twillman; A I Vinik Journal: Neurogastroenterol Motil Date: 2006-04 Impact factor: 3.598
Authors: Christine de la Loge; Elyse Trudeau; Patrick Marquis; Peter Kahrilas; Vincenzo Stanghellini; Nicholas J Talley; Jan Tack; Dennis A Revicki; Anne M Rentz; Dominique Dubois Journal: Qual Life Res Date: 2004-12 Impact factor: 4.147
Authors: G Tougas; E Y Eaker; T L Abell; H Abrahamsson; M Boivin; J Chen; M P Hocking; E M Quigley; K L Koch; A Z Tokayer; V Stanghellini; Y Chen; J D Huizinga; J Rydén; I Bourgeois; R W McCallum Journal: Am J Gastroenterol Date: 2000-06 Impact factor: 10.864
Authors: Henry P Parkman; Katherine Yates; William L Hasler; Linda Nguyen; Pankaj J Pasricha; William J Snape; Gianrico Farrugia; Kenneth L Koch; Thomas L Abell; Richard W McCallum; Linda Lee; Aynur Unalp-Arida; James Tonascia; Frank Hamilton Journal: Gastroenterology Date: 2010-10-20 Impact factor: 22.682
Authors: D A Revicki; A M Rentz; D Dubois; P Kahrilas; V Stanghellini; N J Talley; J Tack Journal: Aliment Pharmacol Ther Date: 2003-07-01 Impact factor: 8.171
Authors: Houssam Halawi; Michael Camilleri; Andres Acosta; Maria Vazquez-Roque; Ibironke Oduyebo; Duane Burton; Irene Busciglio; Alan R Zinsmeister Journal: Am J Physiol Gastrointest Liver Physiol Date: 2017-08-03 Impact factor: 4.052
Authors: Henry P Parkman; Laura A Wilson; William L Hasler; Richard W McCallum; Irene Sarosiek; Kenneth L Koch; Thomas L Abell; Ron Schey; Braden Kuo; William J Snape; Linda Nguyen; Gianrico Farrugia; Mandhusudan Grover; John Clarke; Laura Miriel; James Tonascia; Frank Hamilton; Pankaj J Pasricha Journal: Dig Dis Sci Date: 2019-03-09 Impact factor: 3.199
Authors: William L Hasler; Laura A Wilson; Linda A Nguyen; William J Snape; Thomas L Abell; Kenneth L Koch; Richard W McCallum; Pankaj J Pasricha; Irene Sarosiek; Gianrico Farrugia; Madhusudan Grover; Linda A Lee; Laura Miriel; James Tonascia; Frank A Hamilton; Henry P Parkman Journal: Clin Gastroenterol Hepatol Date: 2018-10-13 Impact factor: 11.382
Authors: Henry P Parkman; Emily P Sharkey; Linda A Nguyen; Katherine P Yates; Thomas L Abell; William L Hasler; William Snape; John Clarke; Ron Schey; Kenneth L Koch; Braden Kuo; Richard W McCallum; Irene Sarosiek; Madhusudan Grover; Gianrico Farrugia; James Tonascia; Pankaj J Pasricha Journal: Dig Dis Sci Date: 2019-11-22 Impact factor: 3.199
Authors: Michael Camilleri; Richard W McCallum; Jan Tack; Sharon C Spence; Keith Gottesdiener; Fred T Fiedorek Journal: Gastroenterology Date: 2017-07-29 Impact factor: 22.682
Authors: Henry P Parkman; Laura A Wilson; Gianrico Farrugia; Kenneth L Koch; William L Hasler; Linda A Nguyen; Thomas L Abell; William Snape; John Clarke; Braden Kuo; Richard W McCallum; Irene Sarosiek; Madhusudan Grover; Laura Miriel; James Tonascia; Frank A Hamilton; Pankaj J Pasricha Journal: Am J Gastroenterol Date: 2019-11 Impact factor: 10.864
Authors: Kenneth L Koch; William L Hasler; Mark Van Natta; Jorge Calles-Escandon; Madhusudan Grover; Pankaj J Pasricha; William J Snape; Henry P Parkman; Thomas L Abell; Richard W McCallum; Linda A Nguyen; Irene Sarosiek; Gianrico Farrugia; James Tonascia; Linda Lee; Laura Miriel; Frank Hamilton Journal: Neurogastroenterol Motil Date: 2019-10-01 Impact factor: 3.598